Rules-Based Medicine Takes Majority Stake in Psynova | GenomeWeb

NEW YORK (GenomeWeb News) – Rules-Based Medicine and Psynova Neurotech said today that they have reached a milestone in their biomarker discovery alliance, and as a result RBM has made additional investments in Psynova, giving it a controlling interest in the firm.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.